<DOC>
	<DOCNO>NCT02307006</DOCNO>
	<brief_summary>The study randomize double-blinded study compare ceftaroline standard care therapy cefazolin vancomycin surgical prophylaxis high risk orthopedic cardiac surgery . Study participant enrol undergoing cardiothoracic surgery involve sternotomy undergoing prosthetic joint replacement either hip knee . Consenting patient randomize 2:1 receive either ceftaroline cefazolin/vancomycin . This study blind use placebo vancomycin infusion placebo cephalosporin infusion . The primary end point development surgical site infection within 30 day surgery .</brief_summary>
	<brief_title>The Use Ceftaroline Surgical Prophylaxis Surgery With Risk MRSA Infection</brief_title>
	<detailed_description>The study randomize double-blinded study compare ceftaroline standard care therapy cefazolin vancomycin surgical prophylaxis high risk orthopedic cardiac surgery . Study participant enrol undergoing cardiothoracic surgery involve sternotomy undergoing prosthetic joint replacement either hip knee . Consenting patient randomize 2:1 receive either ceftaroline cefazolin/vancomycin . This study blind use placebo vancomycin infusion placebo cephalosporin infusion . Study participant enrol 2 population patient ; undergo cardiothoracic surgery sternotomy undergo prosthetic joint replacement either hip knee . Subjects identify primary surgical service . Adult subject 18 year old notify study agreeable interview study coordinator explain study study procedure determine eligibility . Informed consent obtain potential participant . Enrollment consent may obtain seven day prior surgery . Consented participant detailed history perform particular reference prior surgical infection , risk factor diabetes , smoking , prior skin infection obesity . Participants undergo physical examination . Patients assess naris colonization methicillin-resistant Staphylococcus aureus ( MRSA ) per primary surgeon 's standard procedure . Patients identify positive MRSA colonization decolonize mupirocin . Female participant serum beta-human chorionic gonadotrophin ( HCG ) assay perform exclude pregnancy . Consented participant randomize 2:1 receive either ceftaroline cefazolin/vancomycin , current regimen high risk individual . Randomization perform blind individual use randomization program . Within group , participant allocate 2:1 ratio . On day surgery , patient evaluate change medical history , vital sign record bilateral naris swab obtain Staphylococcal screen MRSA methicillin-sensitive Staphylococcus aureus ( MSSA ) carriage . All patient receive pre-operative towel operative site chlorhexidine , surgical skin preparation chlorhexidine/alcohol ( Duraprep ) . Consented participant receive two blind infusion . Study infusion prepare unblinded pharmacist match active medication . Placebo study medication match volume appearance . Dosing vancomycin cefazolin weight base 120 kg 15 mg/kg 25 mg/kg respectively . ceftaroline administer dose 600 mg individual estimate creatinine clearance great 50 ml/min 400 mg creatinine clearance rate 30-50 ml/min . Vancomycin placebo1 start 120 minute prior incision complete within 60 minute prior surgery . The cefazolin ceftaroline start 60 minute surgery complete 30 minute prior incision . Each participant thus receive 2 infusion T-120 T-60 minute time skin incision . Patients redo antibiotic 1.5 2 half-lives ( cefazolin ceftaroline 4hrs hour post skin incision vancomycin/placebo 1 12 hr ) prolong procedure . One post-operative dose cefazolin/ceftraroline give recovery room 4 hour skin incision patient redosed procedure orthopedic procedure 2 dos administer cardiothoracic procedure . Pharmacokinetic substudy : Because variation pharmacokinetics previously identify patient undergo extracorporeal circulation , perform pharmacokinetic analysis subset 50 patient cardiac surgery arm study allow data least 30 patient receive ceftaroline . Plasma sample collect start infusion ( time = 0 , Sample # 1 ) , end infusion ( time = 30 minute , Sample # 2 ) , 15 minute post infusion ( Sample # 3 ) , time skin incision ( Sample # 4 ) commencement cardiopulmonary bypass ( CPB ) ( Sample # 5 ) , completion CPB ( Sample # 6 ) time skin closure ( Sample # 7 ) . Samples analyze high pressure liquid chromatography ( HPLC ) determine ceftaroline level use know plasma standard appropriate quality control . Patients undergo wound inspection study personnel prior discharge hospital . Microbiological culture obtain surgical site infection . All isolates report . Patients interview examined day 30 presence evidence surgical site infection operative site . Subjects question regard presence fever , redness drainage manifestation infection . Physical examination finding surgical team prior post-operative visit review correlate data obtain subject . The primary end point development surgical site infection within 30 day surgery . 30 day surgical site infection rate either primary surgical site remote surgical site ( e.g . vein donor site CABG procedure ) use principal outcome measure . Surgical site infection characterize superficial ( fascia ) complex ( deep ( extend fascia ) organ involve ) , Secondary endpoint record include ( ) infection , viz . pulmonary , UTI , line relate ) ; ( ii ) Drug relate , viz. , rash , itching ; ( iii ) nausea , vomit ( iiii ) return OR .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Informed Consent Age 18 year old Patients undergo either hip knee arthroplasty cardiac surgery sternotomy Body mass index ( BMI ) 18 30 kg/m2 inclusive . Female subject must negative serum pregnancy test use appropriate contraception . Pregnancy Hypersensitivity allergic reaction βlactam antibiotic vancomycin . Presence cardiovascular shock , Receipt chronic concomitant systemic corticosteroid , 40 mg prednisone equivalent ; Severe renal impairment ( i.e . Creatinine clearance ≤ 30 mL/min ) ; Significant hepatic impairment ( i.e . know acute viral hepatitis , aspartate aminotransferase alanine aminotransferase concentration 10fold upper limit normal ( ULN ) total bilirubin 3fold ULN manifestation endstage liver disease , ascites hepatic encephalopathy ) , Hematological impairment current anticipate neutropenia le 500 neutrophils/mm3 thrombocytopenia platelet count 60 000 cells/mm3 HIV infection time screen meet 2008 CDC criterion AIDS . Patients undergo revision surgery infect prosthetic joint replacement . Body mass index ( BMI ) less 18 great 30 kg/m2 . Concurrent antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>